Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

322 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Recommendations for the use of rituximab (anti-CD20 antibody) in the treatment of autoimmune bullous skin diseases.
Hertl M, Zillikens D, Borradori L, Bruckner-Tuderman L, Burckhard H, Eming R, Engert A, Goebeler M, Hofmann S, Hunzelmann N, Karlhofer F, Kautz O, Lippert U, Niedermeier A, Nitschke M, Pfütze M, Reiser M, Rose C, Schmidt E, Shimanovich I, Sticherling M, Wolff-Franke S. Hertl M, et al. Among authors: hunzelmann n. J Dtsch Dermatol Ges. 2008 May;6(5):366-73. doi: 10.1111/j.1610-0387.2007.06602.x. Epub 2008 Jan 14. J Dtsch Dermatol Ges. 2008. PMID: 18201220 English, German.
IgA autoantibodies in the pemphigoids and linear IgA bullous dermatosis.
Horváth B, Niedermeier A, Podstawa E, Müller R, Hunzelmann N, Kárpáti S, Hertl M. Horváth B, et al. Among authors: hunzelmann n. Exp Dermatol. 2010 Jul 1;19(7):648-53. doi: 10.1111/j.1600-0625.2010.01080.x. Epub 2010 May 25. Exp Dermatol. 2010. PMID: 20500772
Generation of increased numbers of HLA-DR(high) IgG+ plasma cells in the peripheral blood of patients with bullous pemphigoid: NC16a-specific cells belong to the short-lived plasma blast population.
László S, Neumann S, Hertl M, Hunzelmann N. László S, et al. Among authors: hunzelmann n. J Invest Dermatol. 2010 Dec;130(12):2838-41. doi: 10.1038/jid.2010.213. Epub 2010 Jul 29. J Invest Dermatol. 2010. PMID: 20668469 Free article. No abstract available.
S2k guideline for the diagnosis of pemphigus vulgaris/foliaceus and bullous pemphigoid.
Schmidt E, Goebeler M, Hertl M, Sárdy M, Sitaru C, Eming R, Hofmann SC, Hunzelmann N, Kern JS, Kramer H, Orzechowski HD, Pfeiffer C, Schuster V, Sporbeck B, Sticherling M, Worm M, Zillikens D, Nast A. Schmidt E, et al. Among authors: hunzelmann n. J Dtsch Dermatol Ges. 2015 Jul;13(7):713-27. doi: 10.1111/ddg.12612. J Dtsch Dermatol Ges. 2015. PMID: 26110729 English, German. No abstract available.
S2k guidelines for the treatment of pemphigus vulgaris/foliaceus and bullous pemphigoid.
Eming R, Sticherling M, Hofmann SC, Hunzelmann N, Kern JS, Kramer H, Pfeiffer C, Schuster V, Zillikens D, Goebeler M, Hertl M, Nast A, Orzechowski HD, Sárdy M, Schmidt E, Sitaru C, Sporbeck B, Worm M. Eming R, et al. Among authors: hunzelmann n. J Dtsch Dermatol Ges. 2015 Aug;13(8):833-44. doi: 10.1111/ddg.12606. J Dtsch Dermatol Ges. 2015. PMID: 26213827 No abstract available.
S2k guidelines for the treatment of pemphigus vulgaris/foliaceus and bullous pemphigoid: 2019 update.
Schmidt E, Sticherling M, Sárdy M, Eming R, Goebeler M, Hertl M, Hofmann SC, Hunzelmann N, Kern JS, Kramer H, Nast A, Orzechowski HD, Pfeiffer C, Schuster V, Sitaru C, Zidane M, Zillikens D, Worm M. Schmidt E, et al. Among authors: hunzelmann n. J Dtsch Dermatol Ges. 2020 May;18(5):516-526. doi: 10.1111/ddg.14097. J Dtsch Dermatol Ges. 2020. PMID: 32413212 No abstract available.
322 results